Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Munehiro Kitada

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Diabetes|July 25, 2012
Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCβ activation in diabetesAkira Mima, Junko Hiraoka-Yamomoto, Qian Li, et al.
Investigative Ophthalmology & Visual Science|December 1, 2012
Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetesAkira Mima, Weier Qi, Junko Hiraoka-Yamomoto, et al.
Clinical Case Reports|June 9, 2018
Severe electrolytes disorders with the interstitial kidney alterations in the patient with the history of total thyroidectomy and parathyroidectomy: possible role of vitamin D deficiencyEmi Kawakita, Keizo Kanasaki, Taro Hirai, et al.
Journal of Diabetes Investigation|May 21, 2014
Three ileus cases associated with the use of dipeptidyl peptidase-4 inhibitors in diabetic patientsKeizo Kanasaki, Kazunori Konishi, Ranji Hayashi, et al.
Plos One|December 30, 2016
Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled TrialTakashi Uzu, Shin-Ichi Araki, Atsunori Kashiwagi, et al.
Journal of Diabetes Investigation|October 9, 2025
Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open-label clinical trial (RESOLUTION study)Munehiro Kitada, Masao Toyoda, Osamu Sekine, et al.
Diabetes, Obesity & Metabolism|May 2, 2022
Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE studySatoshi Miyamoto, Hiddo J L Heerspink, Dick de Zeeuw, et al.
Kidney International Reports|March 30, 2026
Cystatin C Confirms the Canagliflozin eGFR Slope Benefit in CANPIONESatoshi Miyamoto, Hiddo J L Heerspink, Dick de Zeeuw, et al.
Kidney International|August 31, 2024
A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slopeSatoshi Miyamoto, Hiddo J L Heerspink, Dick de Zeeuw, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Diabetes|July 25, 2012
Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCβ activation in diabetesAkira Mima, Junko Hiraoka-Yamomoto, Qian Li, et al.
Investigative Ophthalmology & Visual Science|December 1, 2012
Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetesAkira Mima, Weier Qi, Junko Hiraoka-Yamomoto, et al.
Clinical Case Reports|June 9, 2018
Severe electrolytes disorders with the interstitial kidney alterations in the patient with the history of total thyroidectomy and parathyroidectomy: possible role of vitamin D deficiencyEmi Kawakita, Keizo Kanasaki, Taro Hirai, et al.
Journal of Diabetes Investigation|May 21, 2014
Three ileus cases associated with the use of dipeptidyl peptidase-4 inhibitors in diabetic patientsKeizo Kanasaki, Kazunori Konishi, Ranji Hayashi, et al.
Plos One|December 30, 2016
Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled TrialTakashi Uzu, Shin-Ichi Araki, Atsunori Kashiwagi, et al.
Journal of Diabetes Investigation|October 9, 2025
Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open-label clinical trial (RESOLUTION study)Munehiro Kitada, Masao Toyoda, Osamu Sekine, et al.
Diabetes, Obesity & Metabolism|May 2, 2022
Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE studySatoshi Miyamoto, Hiddo J L Heerspink, Dick de Zeeuw, et al.
Kidney International Reports|March 30, 2026
Cystatin C Confirms the Canagliflozin eGFR Slope Benefit in CANPIONESatoshi Miyamoto, Hiddo J L Heerspink, Dick de Zeeuw, et al.
Kidney International|August 31, 2024
A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slopeSatoshi Miyamoto, Hiddo J L Heerspink, Dick de Zeeuw, et al.
Pageof 10